USANA HEALTH SCIENCES, INC. Derivative Notional Amount
USANA HEALTH SCIENCES, INC. (USNA) had Derivative Notional Amount of $70.06 million as of 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Notes
us-gaap:DerivativeNotionalAmount · last filed 2026-03-16
- 2026-01-03: Derivative, Notional Amount $70.06M.
- 2024-12-28: Derivative, Notional Amount $77.34M.
- 2023-12-30: Derivative, Notional Amount $81.34M.
- 2022-12-31: Derivative, Notional Amount $98.93M.
| Period end | Derivative, Notional Amount |
|---|---|
| 2026-01-03 | $70.06M 10-K · filed 2026-03-16 |
| 2024-12-28 | $77.34M 10-K · filed 2025-03-12 |
| 2023-12-30 | $81.34M 10-K · filed 2024-02-27 |
| 2022-12-31 | $98.93M 10-K · filed 2023-02-28 |
| 2022-10-01 | $98.93M 10-Q · filed 2022-11-08 |
| 2022-07-02 | $98.93M 10-Q · filed 2022-08-09 |
| 2022-04-02 | $98.93M 10-Q · filed 2022-05-11 |
| 2022-01-01 | $98.68M 10-K · filed 2022-03-01 |
| 2021-10-02 | $98.68M 10-Q · filed 2022-11-08 |
| 2021-07-03 | $98.68M 10-Q · filed 2022-08-09 |
| 2021-04-03 | $98.68M 10-Q · filed 2022-05-11 |
| 2020-09-26 | $90.00M 10-Q · filed 2021-11-10 |
| 2020-06-27 | $90.00M 10-Q · filed 2020-08-04 |
| 2020-03-28 | $90.00M 10-Q · filed 2021-08-11 |
| 2019-12-28 | $110.00M 10-K · filed 2020-02-25 |
| 2019-09-28 | $110.00M 10-Q · filed 2020-11-03 |
| 2019-06-29 | $110.00M 10-Q · filed 2020-08-04 |
| 2019-03-30 | $110.00M 10-Q · filed 2020-05-05 |
| 2018-12-29 | $105.00M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |